Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Linear B Cell Epitopes Derived from the Multifunctional Surface Lipoprotein BBK32 as Targets for the Serodiagnosis of Lyme Disease.

Toumanios C, Prisco L, Dattwyler RJ, Arnaboldi PM.

mSphere. 2019 May 1;4(3). pii: e00111-19. doi: 10.1128/mSphere.00111-19.

2.

Borrelia burgdorferi-specific IgA in Lyme Disease.

D'Arco C, Dattwyler RJ, Arnaboldi PM.

EBioMedicine. 2017 May;19:91-97. doi: 10.1016/j.ebiom.2017.04.025. Epub 2017 Apr 21.

3.

Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.

Arnaboldi PM, Sambir M, D'Arco C, Peters LA, Seegers JF, Mayer L, McCormick AA, Dattwyler RJ.

Vaccine. 2016 Nov 11;34(47):5768-5776. doi: 10.1016/j.vaccine.2016.09.063. Epub 2016 Oct 13.

4.

Detection of IFN-γ Secretion by T Cells Collected Before and After Successful Treatment of Early Lyme Disease.

Callister SM, Jobe DA, Stuparic-Stancic A, Miyamasu M, Boyle J, Dattwyler RJ, Arnaboldi PM.

Clin Infect Dis. 2016 May 15;62(10):1235-1241. doi: 10.1093/cid/ciw112. Epub 2016 Mar 1.

5.

Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.

Lahey LJ, Panas MW, Mao R, Delanoy M, Flanagan JJ, Binder SR, Rebman AW, Montoya JG, Soloski MJ, Steere AC, Dattwyler RJ, Arnaboldi PM, Aucott JN, Robinson WH.

J Clin Microbiol. 2015 Dec;53(12):3834-41. doi: 10.1128/JCM.02111-15. Epub 2015 Oct 7.

6.

Cross-Reactive Epitopes in Borrelia burgdorferi p66.

Arnaboldi PM, Dattwyler RJ.

Clin Vaccine Immunol. 2015 Jul;22(7):840-3. doi: 10.1128/CVI.00217-15. Epub 2015 May 13.

7.

Comparison of lyme disease serologic assays and lyme specialty laboratories.

Dattwyler RJ, Arnaboldi PM.

Clin Infect Dis. 2014 Dec 15;59(12):1711-3. doi: 10.1093/cid/ciu705. Epub 2014 Sep 2. No abstract available.

PMID:
25182243
8.

Decorin binding proteins A and B in the serodiagnosis of Lyme disease in North America.

Arnaboldi PM, Sambir M, Dattwyler RJ.

Clin Vaccine Immunol. 2014 Oct;21(10):1426-36. doi: 10.1128/CVI.00383-14. Epub 2014 Aug 13.

9.

Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.

Signorino G, Arnaboldi PM, Petzke MM, Dattwyler RJ.

Clin Vaccine Immunol. 2014 May;21(5):704-11. doi: 10.1128/CVI.00792-13. Epub 2014 Mar 12.

10.

Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme disease.

Arnaboldi PM, Seedarnee R, Sambir M, Callister SM, Imparato JA, Dattwyler RJ.

Clin Vaccine Immunol. 2013 Apr;20(4):474-81. doi: 10.1128/CVI.00608-12. Epub 2013 Jan 30.

11.

Suppression of Th1 and Th17, but not Th2, responses in a CD8(+) T cell-mediated model of oral tolerance.

Arnaboldi PM, Roth-Walter F, Mayer L.

Mucosal Immunol. 2009 Sep;2(5):427-38. doi: 10.1038/mi.2009.93. Epub 2009 Jul 1.

12.

Mucosal B cell deficiency in IgA-/- mice abrogates the development of allergic lung inflammation.

Arnaboldi PM, Behr MJ, Metzger DW.

J Immunol. 2005 Jul 15;175(2):1276-85.

13.

Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity.

Huber VC, Arulanandam BP, Arnaboldi PM, Elmore MK, Sheehan CE, Kallakury BV, Metzger DW.

Int Immunopharmacol. 2003 Jun;3(6):801-9.

PMID:
12781697

Supplemental Content

Loading ...
Support Center